A: A synthetic peptide representing the active region of Thymosin Beta-4 (amino acids 17-23 of the naturally occurring 43-AA peptide) believed responsible for most of its biological activity in research models
Log your protocol in PeptIQ to see patterns across all these variables over time
Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes
Some studies suggest tirzepatide may produce somewhat greater weight loss in some populations, but direct head-to-head comparisons are limited, and "better" depends entirely on individual factors
The body fights sustained caloric restriction through metabolic adaptation, making willpower alone often insufficient for substantial weight loss
Most GLP-1 medications are administered via subcutaneous injection weekly (semaglutide, dulaglutide, exenatide extended-release) or daily (liraglutide), with oral semaglutide (Rybelsus) representing the only currently available oral formulation